Healthcare Triangle, Inc. reports developments in healthcare information technology, digital health platforms, cloud enablement, managed services, and data analytics for healthcare and life sciences organizations. Company news includes product and customer updates involving hospital information management, interoperability, telehealth, AI-powered clinical and operational automation, and customer-engagement tools.
Recurring HCTI updates also cover subsidiary activity at QuantumNexis, international expansion across Africa, the Middle East, and related healthcare markets, partnership and joint-venture activity, and capital-structure actions such as share repurchase authorization and reverse stock split disclosures.
Healthcare Triangle (Nasdaq: HCTI) announced on Oct 3, 2025 that holders agreed to immediately exercise outstanding warrants to buy 377,702 common shares for aggregate gross proceeds of approximately $755,000. In return, those holders will receive new unregistered warrants to purchase up to 377,702 shares at an exercise price of $3.00 per share.
The company reduced the exercise price of the Existing Warrants from $20.92 to $2.00. The New Warrants are immediately exercisable, expire five years from issuance, and the transactions are expected to close on or about Oct 6, 2025. WallachBeth Capital is acting as financial advisor. Gross proceeds exclude any future New Warrant exercises and will be reduced by advisor fees and transaction expenses.
Healthcare Triangle (NASDAQ:HCTI) has secured approximately $1.63 million in gross proceeds through warrant exercise agreements with three existing accredited investors. The agreement involves the immediate exercise of existing warrants to purchase 812,775 shares of common stock, with the exercise price reduced from $20.92 to $2.00 per share.
In exchange, investors will receive new unregistered warrants to purchase an additional 812,775 shares at $3.00 per share, exercisable upon stockholder approval and expiring five years thereafter. WallachBeth Capital is serving as the sole placement agent for this warrant inducement transaction, expected to close on October 2, 2025.
Healthcare Triangle (Nasdaq: HCTI) announced that its subsidiary QuantumNexis's Ezovion EMR platform has processed over $20 million in revenue from healthcare providers. The company projects this figure to reach $37 million within six months as it expands into India, Bangladesh, Saudi Arabia, and Malaysia.
QuantumNexis plans to launch a proprietary integrated payment gateway that will generate 0.05% (five basis points) of all revenue processed through the platform. The platform operates on a consumption-based model, enabling healthcare providers to digitize and manage their operations while creating a scalable revenue stream for HCTI through transaction-based fees.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.